跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
anti-androgens
首页
药物
anti-androgens
anti-androgens
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
EP 2900224 A1
申请人: ARAGON PHARMACEUTICALS INC
优先权: 2012
CN
EP
US
WO
20 件公开
ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
EP 4438126 A3
申请人: ARAGON PHARMACEUTICALS INC
优先权: 2017
CN
EP
US
WO
14 件公开
Chroman-derived anti-androgens for treatment of androgen-mediated disorders
US 7709525 B2
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2004
US
9 件公开
ANTI-ANDROGEN OR AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATMENT OF A VIRAL RESPIRATORY INFECTION
EP 4125828 A1
申请人: SUZHOU KINTOR PHARMACEUTICALS INC
优先权: 2020
EP
US
8 件公开
WO 2021202014 A1
申请人: APPLIED BIOLOGY INC
优先权: 2020
WO
2 件公开
Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
US 7550505 B2
申请人: UNIV DELAWARE
优先权: 2007
US
4 件公开
US 8450374 B2
申请人: KOH JOHN TZE-TZUN
优先权: 2010
US
2 件公开
Combinations comprising epothilones and pharmaceutical uses thereof
US 2005271669 A1
申请人: HOHNEKER JOHN A
优先权: 2002
EP
US
3 件公开
Methods and materials for assessing prostate cancer therapies
EP 2299266 A1
申请人: UNIV CALIFORNIA
优先权: 2004
EP
US
3 件公开
Methods and materials for assessing prostate cancer therapies and compounds
US 7718684 B2
申请人: UNIV CALIFORNIA
优先权: 2005
US
3 件公开
ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS
US 2023133119 A1
申请人: UNIV SOUTHERN CALIFORNIA
优先权: 2021
US
3 件公开
EP 4121044 A4
申请人: UNIV SOUTHERN CALIFORNIA
优先权: 2020
EP
US
2 件公开
Pharmaceutical composition
US 2007196269 A1
申请人: SCHLINGENSIEPEN KARL-HERMANN
优先权: 2004
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈